Login
Toggle sidebar

Lint: glioma-treatment-response-assessment-in-clinical-trials

glioma-treatment-response-assessment-in-clinical-trials
Acronyms
warning

"Currently, the most widely used system to assess first line treatment response in glioblastomas (and lower grade diffuse astrocytomas) are the Response Assessment in Neuro-Oncology Criteria (RANO), which were published in 2010 1."

Line 8:212 · 'RANO' has no definition. Spell it out if it's unfamiliar to the audience.

"RANO criteria (2010) 1"

Line 27:7 · 'RANO' has no definition. Spell it out if it's unfamiliar to the audience.

"modified RANO criteria (2017) 5"

Line 34:17 · 'RANO' has no definition. Spell it out if it's unfamiliar to the audience.

"RTOG 0825 criteria"

Line 35:11 · 'RTOG' has no definition. Spell it out if it's unfamiliar to the audience.

"RANO 2.0 criteria (2023) 6"

Line 36:8 · 'RANO' has no definition. Spell it out if it's unfamiliar to the audience.
List Caps
warning

"Levin criteria"

Line 12:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"World Health Organizatiοn (WHO) oncology response criteria"

Line 13:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Macdonald criteria (1990) 2"

Line 15:7 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"Response Evaluation Criteria in Solid Tumours (RECIST)"

Line 19:7 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Previous systems"

Line 10:1 · "Previous systems" is not a recognised heading for this article type.
Inline EG
suggestion

"improved understanding of tumour biology (e.g. appreciating the importance of non-enhancing tumour)"

Line 3:49 · Consider replacing a bracketed e.g. with an inline e.g. after a comma.

"the realisation that existing criteria are flawed (e.g. measuring necrotic tumours)"

Line 4:58 · Consider replacing a bracketed e.g. with an inline e.g. after a comma.
Recency
suggestion

"Currently, the most widely used system to assess first line treatment response in glioblastomas (and lower grade diffuse astrocytomas) are the Response Assessment in Neuro-Oncology Criteria (RANO), which were published in 2010 1."

Line 8:4 · Avoid describing evidence as recent; give a date instead: 'Currently'.

"currently the most widely used system, representing a refinement of the Macdonald criteria"

Line 28:12 · Avoid describing evidence as recent; give a date instead: 'currently'.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0